NCT00416611

Brief Summary

The objective of this protocol is to improve awareness, treatment, and control of arterial hypertension, within primary prevention of target organ damage, by implementing guidelines, after training of the participating physicians.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2006

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 23, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 28, 2006

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
Last Updated

January 29, 2009

Status Verified

January 1, 2009

Enrollment Period

1 year

First QC Date

December 23, 2006

Last Update Submit

January 28, 2009

Conditions

High Blood Pressure

Keywords

High blood pressureAwarenessTreatmentEffective ControlCoronary heart disease risk reductionHypertension

Outcome Measures

Primary Outcomes (2)

  • Efficacy in arterial hypertension control

    6 months

  • Efficacy in reducing estimated risk of coronary heart disease

    6 months

Secondary Outcomes (2)

  • Cost effectiveness of arterial hypertension control

    6 months

  • Differences between primary and secondary health care settings as well as teaching hospitals

    6 months

Interventions

Implementation of guidelinesBEHAVIORAL

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Arterial hypertension as defined by the JNC 7 report

You may not qualify if:

  • Pregnancy
  • Lactation
  • Malignancies with small life expectancy
  • Unwillingness to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hellenic Atherosclerosis Society

Thessaloniki, Thessaloniki, 55132, Greece

Location

Related Publications (2)

  • Karagiannis A, Athyros VG, Papageorgiou A, Tziomalos K, Elisaf M. Should atenolol still be recommended as first-line therapy for primary hypertension? Hellenic J Cardiol. 2006 Sep-Oct;47(5):298-307. No abstract available.

    PMID: 17134065RESULT

  • Karagiannis A, Hatzitolios AI, Athyros VG, Deligianni K, Charalambous C, Papathanakis C, Theodosiou G, Drakidis T, Chatzikaloudi V, Kamilali C, Matsiras S, Matziris A, Savopoulos C, Baltatzi M, Rudolf J, Tziomalos K, Mikhailidis DP. Implementation of guidelines for the management of arterial hypertension. The impulsion study. Open Cardiovasc Med J. 2009 May 5;3:26-34. doi: 10.2174/1874192400903010026.

    PMID: 19557149DERIVED

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Athyros G Athyros, MD

    Clinical Trials Chair of Hellenic Atherosclerosis Society

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 23, 2006

First Posted

December 28, 2006

Study Start

November 1, 2006

Primary Completion

November 1, 2007

Study Completion

November 1, 2007

Last Updated

January 29, 2009

Record last verified: 2009-01

Locations

GR(1)